The Acute Myeloid Leukemia (AML) market is witnessing significant shifts driven by advances in targeted therapies and precision medicine. https://hallbook.com.br/blogs/696314/Acute-Myeloid-Leukemia-Market-Size-and-Growth-Driven-by-Innovative#google_vignette